Advertisement

Topics

FDA Okays Perampanel Monotherapy for Partial-Onset Seizures

05:34 EDT 28 Jul 2017 | Medscape

The FDA has approved perampanel as monotherapy to treat partial-onset seizures in patients with epilepsy with or without secondarily generalized seizures.
Medscape Medical News

Original Article: FDA Okays Perampanel Monotherapy for Partial-Onset Seizures

NEXT ARTICLE

More From BioPortfolio on "FDA Okays Perampanel Monotherapy for Partial-Onset Seizures"

Quick Search
Advertisement
 

Relevant Topic

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...